Advisory Committee on Immunization Practices February Meeting Postponed

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Feb 26, 2025.

By Stephanie Brown HealthDay Reporter

WEDNESDAY, Feb. 26, 2025 -- The latest meeting of the U.S. Centers for Disease Control and Prevention Advisory Committee on Immunization Practices (ACIP) has been postponed indefinitely to allow time for public comments to be collected, according to federal health officials, Reuters has reported.

ACIP usually holds multiple meetings each year to review scientific data and make recommendations to the director of the CDC. This particular meeting, originally scheduled for Feb. 26 to 28, was to include several important votes, including one about how a key government vaccine distribution program should handle influenza inoculations. The draft agenda also indicated reviews of the GSK meningococcal vaccine and AstraZeneca flu shot.

According to the U.S. Department of Health and Human Services, the public is normally allowed time to submit written comments in advance of ACIP meetings through a federal portal. Prior to the inauguration of President Trump last month, the CDC had posted a formal notice of the February ACIP meeting, noting that comments could be submitted between Feb. 3 and 17. However, a letter to the newly appointed Secretary of the U.S. Department of Health and Human Services, Robert F. Kennedy Jr., signed by more than 50 medical experts and organizations, states that the portal has been "absent," Reuters reported. The signatories also requested the "critical" meeting be rescheduled.

The American College of Physicians echoed that sentiment. "Our country is currently facing the worst epidemic of influenza in several decades, a measles outbreak in Texas, and an ongoing national outbreak of pertussis," Isaac O. Opole, M.B.Ch.B., Ph.D., president of the American College of Physicians, said in a statement. "The CDC must promptly reschedule this critical meeting. We call on Secretary Kennedy and other officials to ensure that the advice of epidemiologists, researchers, physicians, and other experts in disease and immunizations remains primary in helping to ensure the public's health."

Reuters Article

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-02-27 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords